135426-92-5

Basic information

• Product Name: (S)-4-[[[2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinyl]ethynyl]hydroxyphosphinyl]-3-hydroxybutanoic acid, disodium salt
• CAS NO: 135426-92-5
• Molecular Weight: 537.435
• Mol File: 135426-92-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-4-[[[2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinyl]ethynyl]hydroxyphosphinyl]-3-hydroxybutanoic acid, disodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-[[[2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinyl]ethynyl]hydroxyphosphinyl]-3-hydroxybutanoic acid, disodium salt(135426-92-5)
• EPA Substance Registry System: (S)-4-[[[2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinyl]ethynyl]hydroxyphosphinyl]-3-hydroxybutanoic acid, disodium salt(135426-92-5)

Safety Data

• Hazardous Substances Data: 135426-92-5(Hazardous Substances Data)

Upstream product

• 24922-02-9 Ethyl 3-cyclopropyl-3-oxopropionate 
• 137586-98-2 (S)-3-(tert-Butyl-diphenyl-silanyloxy)-4-{[2-cyclopropyl-4-(4-fluoro-phenyl)-5-methyl-6-phenyl-pyridin-3-ylethynyl]-methoxy-phosphinoyl}-butyric acid methyl ester 
• 137586-95-9 α-(1-Cyclopropyl-1-oxomethyl)-β-(4-fluorophenyl)-γ-methyl-Δ-oxophenylpentanoic acid, ethyl ester 
• 137586-96-0 2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinecarboxylic acid, ethyl ester 
• 135454-81-8 2-cyclopropyl-3-(2,2-dibromoethenyl)-4-(4-fluorophenyl)-5-methyl-6-phenylpyridine 
• 135426-30-1 2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinemethanol 
• 137586-97-1 2-Cyclopropyl-4-(4-fluorophenyl)-5-methyl-6-phenyl-3-pyridinecarboxaldehyde 
• 137586-94-8 (Z)-2-Cyclopropanecarbonyl-3-(4-fluoro-phenyl)-acrylic acid ethyl ester 
• 459-57-4 4-fluorobenzaldehyde 
• 137586-99-3 (S)-4-{[2-Cyclopropyl-4-(4-fluoro-phenyl)-5-methyl-6-phenyl-pyridin-3-ylethynyl]-methoxy-phosphinoyl}-3-hydroxy-butyric acid methyl ester 

Relevant articles and documents

PYRIDINE ANCHORS FOR HMG-COA REDUCTASE INHIBITORS

Compounds which are useful as inhibitors of cholesterol biosynthesis and thus as hypocholesterolemic agents are provided which have a quinoline or a pyridine anchor attached by means of a linker to a binding domain sidechain, which compounds inhibit the e